Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Qiagen; Merck KGaA, Millipore; Pacific Biosciences; Miraculins; iKaryos Diagnostics

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen this week said that it has completed European certification for its careHPV test, which will be used in low-resource, developing countries that recognize the CE mark. The test can be performed in a community facility without mains electricity or running water and offers HPV detection results in a matter of hours, said Qiagen.

The firm also said that it will pursue World Health Organization prequalification — an approval process that allows United Nations agencies to purchase diagnostic technologies for low-income countries. In addition, Qiagen is preparing the submission of its careHPV marketing application to the Chinese State Food & Drug Association.


The European Commission this week cleared Merck KGaA's $7.2 billion agreement to acquire Millipore. The firms expect to close the deal next week.


Pacific Biosciences today launched a software developer' network, called PacBio DevNet, which is intended to support academic informatics developers, life scientists, and independent software vendors interested in creating tools to work with the firm's sequencing data.


Miraculins this week said that it has granted an aggregate of 1,850,000 stock options at an exercise price of C$0.14 (US$.14) per common share to President and CEO Christopher Moreau, a consultant, and certain directors of the firm.


iKaryos Diagnostics this week announced that it has signed up regional distributors to offer its cancer diagnostic services, using the firm's SNP array Virtual Karyoptyes, in Australia, Egypt, Hong Kong, Korea, Kuwait, Saudi Arabia, Singapore, and United Arab Emirates. It did not disclose the names of the distributors.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.